Lenvatinib Capsules
Multiple Receptor Kinase Inhibitor
Lenvatinib Capsules
Aprazer Healthcare – Leading WHO-GMP certified manufacturer and global exporter of Lenvatinib Capsules (Lenvakast). High-quality, reliable, affordable medicine.
Formulation
Capsules
Standard
WHO-GMP Certified Quality
Supply Type
Global Export & Institutional Supply
WHO-GMP Certified
Global Export Ready
Quality Assured
Formulation Insights
Comprehensive Medical Overview
Lenvatinib Capsules
Classification: Multiple Receptor Kinase Inhibitor
About Lenvatinib Capsules
Lenvatinib is a multi-targeted kinase inhibitor that selectively inhibits VEGF receptors (VEGFR1-3), FGFR1-4, RET, KIT, and PDGFRα, used in treating differentiated thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma.
Lenvatinib Capsules (Lenvakast) Manufactured by Aprazer Healthcare
Lenvakast is formulated and manufactured under strict WHO-GMP compliance, delivering proven bioequivalence, therapeutic efficacy, and clinical reliability globally.